If you think registering a medical device is simply submitting documents to Roszdravnadzor and waiting, we have disappointing news for you. It is a full-scale project that can last from several months to several years, cost millions of rubles, and expose problems you never even suspected.
According to Roszdravnadzor, in 2024 alone about 40% of submitted dossiers were returned for revision. And we are not talking about minor quibbles — mistakes at the start cost months of downtime and repeat testing.
Nuance No. 1: Risk class — the foundation that often crumbles
Determining the risk class is not a formality. Everything depends on it: the scope of testing, the composition of the dossier, the need for clinical trials, and even production inspections.
Manufacturers often underestimate the class, hoping for a faster procedure. The result: the regulator identifies the discrepancy and requires a completely new submission from scratch.
A real-world example: software for analysing medical images. It seems like software — Class 2a. But if the software influences a diagnostic decision, it is classified as 2b, and then clinical trials involving patients become inevitable. That means completely different timelines and budgets.
According to Roszdravnadzor, classification errors accounted for about 37% of returns in 2024.
Nuance No. 2: The "small thing" that halts the process
A registration dossier is not just a stack of papers. The absence of even one document that seems insignificant leads to suspension of review.
Translation of instructions into Russian? No — a request. A copy of the ISO 13485 certificate with apostille? No — a return. A biocompatibility protocol according to GOST R ISO 10993? No — the process stops.
Foreign manufacturers are especially prone to errors, submitting dossiers prepared for FDA or European regulator requirements. The logic of the documents is different, and the regulator is not obliged to delve into your explanations.
Nuance No. 3: The authorised representative — your "pass" to the market
A foreign manufacturer cannot register a medical device in Russia directly. Only through an authorised representative — a Russian legal entity acting on behalf of the manufacturer under a power of attorney.
The power of attorney has an expiry date. If it expires and the data is not updated, the registration certificate may be cancelled.
The deadline for updating information on the authorised representative has been extended to September 1, 2027, but that does not mean you can relax. An expired power of attorney is already a violation.
Nuance No. 4: Clinical trials — what you cannot "skip"
For Class 2b and 3 devices, clinical trials are mandatory. This means:
-
finding an accredited medical organisation;
-
developing a trial programme;
-
involving real patients;
-
collecting and analysing data;
-
preparing a report.
The cost of registering a single high-tech medical device can exceed 3 million rubles, and a significant portion of that goes to clinical research.
And if the device design changes or the raw material supplier changes, the trials must be conducted again.
Nuance No. 5: Deadlines that are inexorably tightening
Since March 1, 2025, new registration rules have been in force (Government Decree No. 1684). For domestic manufacturers, the period has been reduced to 10 working days after a positive expert review.
But that applies to those whose documentation is in order. For imported Class 2b and 3 devices with mandatory clinical trials, the actual timelines remain substantial — from 12 months or more.
The transitional period for national registration in the EAEU has been extended to December 31, 2027, and for re-registration — to December 31, 2028. This provides time but does not remove the requirements.
What this means for you
Medical device registration is not bureaucracy. It is a strategy in which every mistake at the start costs months and millions. Manufacturers who treat it as a "formality" lose time, money, and access to the market.
Elibrium knows this path inside out. We specialise in registering medical devices of any complexity — from simple consumables to high-tech Class 3 systems. Our experts:
-
determine the correct risk class and registration route;
-
prepare the dossier in accordance with all requirements of Decree No. 1684;
-
select accredited laboratories and medical centres;
-
organise technical, toxicological, and clinical trials;
-
support the project from application submission to obtaining the registration certificate.
We operate transparently: timelines and costs are fixed in the contract. No "surprises" along the way.
Medical device registration is a strategy. Elibrium offers a route where risks are calculated and the result is guaranteed.
Contact us through our website — we will assess your project and prepare a tailored offer.
